drugset / Trial / NCT00005077

Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction

NCT00005077 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of oxaliplatin in treating patients who have advanced cancer plus liver dysfunction.

Timeline

Start
2000-02
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxaliplatin Small molecule — Intravenous